90% of sports fans want games on local TV, keeping linear central despite streaming’s rise.
40% of US ad buyers say understanding agentic ad buying and campaign execution is one of their top concerns for 2026, according to a January survey from the IAB.
Mobile multitasking is no longer a youth quirk, splintering premium TV audiences and challenging ad recall.
OpenAI’s ChatGPT ads top $100 million in annualized revenues, but fast growth masks weak proof of results.
Netflix and rivals raise prices, driving churn and turning ad-supported plans into the main play.
Siri may let users route queries to Gemini or Claude, loosening OpenAI ties and unlocking new AI app revenues.
AI is speeding up B2B buying without making decisions easier. Buyers move through early research faster and with less vendor contact. Marketers need clear, specific, consistent information across touchpoints—or risk losing ground in evaluation.
While digital in-store retail media remains a small fraction of total retail media spend, the real challenge is integrating digital formats into physical stores thoughtfully to create a cohesive customer experience rather than a fragmented one.
New shoppable placements, unified logins, and strong results tie streaming ads to measurable sales impact.
Bicultural Latinos drive faster spending gains and reward culturally fluent brands with loyalty and action.
Higher fuel, freight, and inflation threaten margins as shoppers grow more price conscious.
A new 8% package fee risks compounding volume declines as Amazon reevaluates its shipping mix.
As consumer spending flattens, issuers and networks are competing for SMB and corporate spending for growth.
The platform’s ability to turn inspiration into sales is driving outsize growth and pushing rivals to invest in social commerce.
As retail media networks use different attribution models, it’s becoming harder for advertisers to compare performance across platforms. Incrementality offers a clearer view of which investments are truly driving growth.
Meta Pay has an opportunity to seize mobile wallet share as social commerce surges among younger consumers.
Full-line closures signal off-price focus as department stores’ luster fades.
Digital formats and trusted clinical settings are turning it into a performance channel driving treatment discussions and uptake.
Merck’s nearly $7 billion acquisition bolsters its cancer portfolio as blockbuster Keytruda nears patent cliff.
When choosing where to buy prescription drugs, brand loyalty takes a back seat to price and access where they already shop.